United States Anti-Aging Drugs Market Report 2017

August 2017 | 114 pages | ID: U073B406C9DEN
QYResearch

Abstracts

In this report, the United States Anti-Aging Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Anti-Aging Drugs in these regions, from 2012 to 2022 (forecast).

United States Anti-Aging Drugs market competition by top manufacturers/players, with Anti-Aging Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• PrivateLabelSk
• Allergan
• Johnson and Johnson
• Alma Lasers
• Photomedex
• Estée Lauder
• Lumenis
• Solta Medical
• Beiersdorf
• Cynosure
• Procter & Gamble
• L'Oreal

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Injections
• Oral Type

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Anti-Aging Drugs for each application, including

• Hospitals
• Clinics

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Anti-Aging Drugs Market Report 2017

1 ANTI-AGING DRUGS OVERVIEW

1.1 Product Overview and Scope of Anti-Aging Drugs
1.2 Classification of Anti-Aging Drugs by Product Category
  1.2.1 United States Anti-Aging Drugs Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Anti-Aging Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Injections
  1.2.4 Oral Type
1.3 United States Anti-Aging Drugs Market by Application/End Users
  1.3.1 United States Anti-Aging Drugs Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospitals
  1.3.3 Clinics
1.4 United States Anti-Aging Drugs Market by Region
  1.4.1 United States Anti-Aging Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Anti-Aging Drugs Status and Prospect (2012-2022)
  1.4.3 Southwest Anti-Aging Drugs Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Anti-Aging Drugs Status and Prospect (2012-2022)
  1.4.5 New England Anti-Aging Drugs Status and Prospect (2012-2022)
  1.4.6 The South Anti-Aging Drugs Status and Prospect (2012-2022)
  1.4.7 The Midwest Anti-Aging Drugs Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Anti-Aging Drugs (2012-2022)
  1.5.1 United States Anti-Aging Drugs Sales and Growth Rate (2012-2022)
  1.5.2 United States Anti-Aging Drugs Revenue and Growth Rate (2012-2022)

2 UNITED STATES ANTI-AGING DRUGS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Anti-Aging Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Anti-Aging Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Anti-Aging Drugs Average Price by Players/Suppliers (2012-2017)
2.4 United States Anti-Aging Drugs Market Competitive Situation and Trends
  2.4.1 United States Anti-Aging Drugs Market Concentration Rate
  2.4.2 United States Anti-Aging Drugs Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Anti-Aging Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES ANTI-AGING DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Anti-Aging Drugs Sales and Market Share by Region (2012-2017)
3.2 United States Anti-Aging Drugs Revenue and Market Share by Region (2012-2017)
3.3 United States Anti-Aging Drugs Price by Region (2012-2017)

4 UNITED STATES ANTI-AGING DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Anti-Aging Drugs Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Anti-Aging Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Anti-Aging Drugs Price by Type (2012-2017)
4.4 United States Anti-Aging Drugs Sales Growth Rate by Type (2012-2017)

5 UNITED STATES ANTI-AGING DRUGS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Anti-Aging Drugs Sales and Market Share by Application (2012-2017)
5.2 United States Anti-Aging Drugs Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES ANTI-AGING DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 PrivateLabelSk
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Anti-Aging Drugs Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 PrivateLabelSk Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Allergan
  6.2.2 Anti-Aging Drugs Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Allergan Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Johnson and Johnson
  6.3.2 Anti-Aging Drugs Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Johnson and Johnson Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Alma Lasers
  6.4.2 Anti-Aging Drugs Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Alma Lasers Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Photomedex
  6.5.2 Anti-Aging Drugs Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Photomedex Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Estee Lauder
  6.6.2 Anti-Aging Drugs Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Estee Lauder Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Lumenis
  6.7.2 Anti-Aging Drugs Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Lumenis Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Solta Medical
  6.8.2 Anti-Aging Drugs Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Solta Medical Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Beiersdorf
  6.9.2 Anti-Aging Drugs Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Beiersdorf Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Cynosure
  6.10.2 Anti-Aging Drugs Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Cynosure Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Procter & Gamble
6.12 L'Oreal

7 ANTI-AGING DRUGS MANUFACTURING COST ANALYSIS

7.1 Anti-Aging Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Anti-Aging Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Anti-Aging Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Anti-Aging Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ANTI-AGING DRUGS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Anti-Aging Drugs Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Anti-Aging Drugs Sales Volume Forecast by Type (2017-2022)
11.3 United States Anti-Aging Drugs Sales Volume Forecast by Application (2017-2022)
11.4 United States Anti-Aging Drugs Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Anti-Aging Drugs
Figure United States Anti-Aging Drugs Market Size (K Units) by Type (2012-2022)
Figure United States Anti-Aging Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Injections Product Picture
Figure Oral Type Product Picture
Figure United States Anti-Aging Drugs Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Anti-Aging Drugs by Application in 2016
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Clinics Examples
Table Key Downstream Customer in Clinics
Figure United States Anti-Aging Drugs Market Size (Million USD) by Region (2012-2022)
Figure The West Anti-Aging Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Anti-Aging Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Anti-Aging Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Anti-Aging Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Anti-Aging Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Anti-Aging Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Anti-Aging Drugs Sales (K Units) and Growth Rate (2012-2022)
Figure United States Anti-Aging Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Anti-Aging Drugs Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Anti-Aging Drugs Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Anti-Aging Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Anti-Aging Drugs Sales Share by Players/Suppliers
Figure 2017 United States Anti-Aging Drugs Sales Share by Players/Suppliers
Figure United States Anti-Aging Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Anti-Aging Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Anti-Aging Drugs Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Anti-Aging Drugs Revenue Share by Players/Suppliers
Figure 2017 United States Anti-Aging Drugs Revenue Share by Players/Suppliers
Table United States Market Anti-Aging Drugs Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Anti-Aging Drugs Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Anti-Aging Drugs Market Share of Top 3 Players/Suppliers
Figure United States Anti-Aging Drugs Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Anti-Aging Drugs Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Anti-Aging Drugs Product Category
Table United States Anti-Aging Drugs Sales (K Units) by Region (2012-2017)
Table United States Anti-Aging Drugs Sales Share by Region (2012-2017)
Figure United States Anti-Aging Drugs Sales Share by Region (2012-2017)
Figure United States Anti-Aging Drugs Sales Market Share by Region in 2016
Table United States Anti-Aging Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Anti-Aging Drugs Revenue Share by Region (2012-2017)
Figure United States Anti-Aging Drugs Revenue Market Share by Region (2012-2017)
Figure United States Anti-Aging Drugs Revenue Market Share by Region in 2016
Table United States Anti-Aging Drugs Price (USD/Unit) by Region (2012-2017)
Table United States Anti-Aging Drugs Sales (K Units) by Type (2012-2017)
Table United States Anti-Aging Drugs Sales Share by Type (2012-2017)
Figure United States Anti-Aging Drugs Sales Share by Type (2012-2017)
Figure United States Anti-Aging Drugs Sales Market Share by Type in 2016
Table United States Anti-Aging Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Anti-Aging Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Anti-Aging Drugs by Type (2012-2017)
Figure Revenue Market Share of Anti-Aging Drugs by Type in 2016
Table United States Anti-Aging Drugs Price (USD/Unit) by Types (2012-2017)
Figure United States Anti-Aging Drugs Sales Growth Rate by Type (2012-2017)
Table United States Anti-Aging Drugs Sales (K Units) by Application (2012-2017)
Table United States Anti-Aging Drugs Sales Market Share by Application (2012-2017)
Figure United States Anti-Aging Drugs Sales Market Share by Application (2012-2017)
Figure United States Anti-Aging Drugs Sales Market Share by Application in 2016
Table United States Anti-Aging Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Anti-Aging Drugs Sales Growth Rate by Application (2012-2017)
Table PrivateLabelSk Basic Information List
Table PrivateLabelSk Anti-Aging Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure PrivateLabelSk Anti-Aging Drugs Sales Growth Rate (2012-2017)
Figure PrivateLabelSk Anti-Aging Drugs Sales Market Share in United States (2012-2017)
Figure PrivateLabelSk Anti-Aging Drugs Revenue Market Share in United States (2012-2017)
Table Allergan Basic Information List
Table Allergan Anti-Aging Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Allergan Anti-Aging Drugs Sales Growth Rate (2012-2017)
Figure Allergan Anti-Aging Drugs Sales Market Share in United States (2012-2017)
Figure Allergan Anti-Aging Drugs Revenue Market Share in United States (2012-2017)
Table Johnson and Johnson Basic Information List
Table Johnson and Johnson Anti-Aging Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Johnson and Johnson Anti-Aging Drugs Sales Growth Rate (2012-2017)
Figure Johnson and Johnson Anti-Aging Drugs Sales Market Share in United States (2012-2017)
Figure Johnson and Johnson Anti-Aging Drugs Revenue Market Share in United States (2012-2017)
Table Alma Lasers Basic Information List
Table Alma Lasers Anti-Aging Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Alma Lasers Anti-Aging Drugs Sales Growth Rate (2012-2017)
Figure Alma Lasers Anti-Aging Drugs Sales Market Share in United States (2012-2017)
Figure Alma Lasers Anti-Aging Drugs Revenue Market Share in United States (2012-2017)
Table Photomedex Basic Information List
Table Photomedex Anti-Aging Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Photomedex Anti-Aging Drugs Sales Growth Rate (2012-2017)
Figure Photomedex Anti-Aging Drugs Sales Market Share in United States (2012-2017)
Figure Photomedex Anti-Aging Drugs Revenue Market Share in United States (2012-2017)
Table Estée Lauder Basic Information List
Table Estée Lauder Anti-Aging Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Estée Lauder Anti-Aging Drugs Sales Growth Rate (2012-2017)
Figure Estée Lauder Anti-Aging Drugs Sales Market Share in United States (2012-2017)
Figure Estée Lauder Anti-Aging Drugs Revenue Market Share in United States (2012-2017)
Table Lumenis Basic Information List
Table Lumenis Anti-Aging Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Lumenis Anti-Aging Drugs Sales Growth Rate (2012-2017)
Figure Lumenis Anti-Aging Drugs Sales Market Share in United States (2012-2017)
Figure Lumenis Anti-Aging Drugs Revenue Market Share in United States (2012-2017)
Table Solta Medical Basic Information List
Table Solta Medical Anti-Aging Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Solta Medical Anti-Aging Drugs Sales Growth Rate (2012-2017)
Figure Solta Medical Anti-Aging Drugs Sales Market Share in United States (2012-2017)
Figure Solta Medical Anti-Aging Drugs Revenue Market Share in United States (2012-2017)
Table Beiersdorf Basic Information List
Table Beiersdorf Anti-Aging Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Beiersdorf Anti-Aging Drugs Sales Growth Rate (2012-2017)
Figure Beiersdorf Anti-Aging Drugs Sales Market Share in United States (2012-2017)
Figure Beiersdorf Anti-Aging Drugs Revenue Market Share in United States (2012-2017)
Table Cynosure Basic Information List
Table Cynosure Anti-Aging Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Cynosure Anti-Aging Drugs Sales Growth Rate (2012-2017)
Figure Cynosure Anti-Aging Drugs Sales Market Share in United States (2012-2017)
Figure Cynosure Anti-Aging Drugs Revenue Market Share in United States (2012-2017)
Table Procter & Gamble Basic Information List
Table L'Oreal Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Anti-Aging Drugs
Figure Manufacturing Process Analysis of Anti-Aging Drugs
Figure Anti-Aging Drugs Industrial Chain Analysis
Table Raw Materials Sources of Anti-Aging Drugs Major Players/Suppliers in 2016
Table Major Buyers of Anti-Aging Drugs
Table Distributors/Traders List
Figure United States Anti-Aging Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Anti-Aging Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Anti-Aging Drugs Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Anti-Aging Drugs Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Anti-Aging Drugs Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Anti-Aging Drugs Sales Volume (K Units) Forecast by Type in 2022
Table United States Anti-Aging Drugs Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Anti-Aging Drugs Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Anti-Aging Drugs Sales Volume (K Units) Forecast by Application in 2022
Table United States Anti-Aging Drugs Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Anti-Aging Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Anti-Aging Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Anti-Aging Drugs Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources